CONMED shares closed at US$51.50, and the recent rebound raises a straightforward question for you as an investor: Is that price supported by what the business is earning today, given how rough the longer term has been for the stock? The share price has fallen 64.7% over 5 years, which puts the focus squarely on whether current earnings now justify where the valuation has reset to. The group depends heavily on consistent procedure volumes and disciplined cost control, so any change in...
Motley Fool Press Release.
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LARGO, Fla., August 26, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA.
This is the newest page. Registered accounts read further back.